Targeted therapeutic solutions meeting COFEPRIS standard compliance for cardiometabolic, endocrine, and vascular indications.
Mexico City (CDMX) stands as the strategic epicenter for pharmaceutical manufacturing, biotechnology R&D, and bulk API distribution across Latin America. Driven by escalating healthcare demand, an expanding middle class, and public health initiatives tackling chronic metabolic disorders, local formulation laboratories in the Metropolitan Area of the Valley of Mexico are rapidly upgrading their finished dosage form (FDF) pipelines.
Key regulatory frameworks governed by COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios) require meticulous documentation, including Drug Master Files (DMF), stability data under ICH Climate Zone IVb conditions, and verified cGMP compliance. Suppliers navigating this market must possess robust supply chains capable of delivering high-purity therapeutic peptides while mitigating regional logistics risks.
Our centralized logistics pathways leverage specialized cold-chain infrastructure via Benito Juárez International Airport (AICM) and Felipe Ángeles International Airport (AIFA), guaranteeing temperature-controlled (−20°C to 2–8°C) integrity from reactor vessel to local CDMX manufacturing sites.
The global peptide market is undergoing unprecedented expansion, anticipated to surpass USD 60 billion by 2030. This growth is predominantly catalyzed by breakthrough innovations in Glucagon-Like Peptide-1 (GLP-1) receptor agonists (such as Semaglutide, Liraglutide, and Dual/Triple Agonists like Tirzepatide and Cagrilintide), alongside targeted peptides for oncology, reproductive endocrinology, and cardiovascular care.
Transitioning from traditional solid-phase peptide synthesis (SPPS) to hybrid liquid-phase methodologies and eco-friendly green peptide chemistries has vastly optimized yield efficiency, purity thresholds, and counterion balance (acetate vs. trifluoroacetate content). Suppliers operating at global scale must integrate real-time quality control analytics—such as LC-MS mass confirmation, RP-HPLC purity profiling, and bacterial endotoxin testing—to ensure seamless international regulatory approval.
Gentolex’s overarching mission is to bridge international biopharmaceutical innovation with reliable local supply chains, delivering uncompromised quality and certified active pharmaceutical ingredients. Serving client networks in over 10 countries, we maintain specialized commercial representatives in Mexico and South Africa to provide responsive, localized technical consultation.
Our core capabilities encompass the supply of commercial-scale peptide APIs, high-throughput custom peptide synthesis, Finished Dosage Form (FDF) licensing solutions, turnkey pharmaceutical line and laboratory setups, as well as end-to-end global procurement strategy.
Exceeding international pharmacopeial specifications (USP, EP, IP) through multi-dimensional analytical validation and continuous quality control.
State-of-the-art automated microwave-assisted SPPS reactors ensure high step-wise yield, minimal racemization, and high purities prior to purification.
Multi-stage preparative Reverse-Phase High-Performance Liquid Chromatography delivers chromatographic purity consistently exceeding ≥98.0% or ≥99.0%.
Rigorous LAL testing guarantees ultra-low bacterial endotoxin levels (<10 EU/mg), fully compliant with injectable formulation requirements.
Explore our validated therapeutic peptide building blocks available for supply, scale-up, and export to Mexico City and international destinations.
Providing holistic scientific support, customized procurement solutions, and licensing capabilities tailored for CDMX pharmaceutical manufacturers.
Flexible sequence design, custom counterion conversion (acetate, HCl, TFA-free), and modified amino acid incorporations at research to commercial scales.
Comprehensive CTD-format dossiers (Module 3) for finished dosage form licensing, speeding up regulatory submission timelines with COFEPRIS.
Complete operational line consultation, analytical method validation transfer, and equipment qualification assistance for local CDMX facilities.
Single-point supply chain management eliminating vendor complexity, securing batch continuity, and providing robust buffer inventory management.
Our network facilities comply with international quality metrics ensuring full traceability and security.
Stay informed with current technical developments, synthetic chemistry breakthroughs, and therapeutic applications.
Selank Acetate API is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) derived from endogenous tuftsin, designed for neuropharmacological research and therapeutic stabilization.
Read Technical Paper
Providing high-purity Thymosin Beta-4 peptide raw materials for biomedical research organizations investigating tissue repair and cellular migration mechanisms.
Read Technical Paper
Synthetic pentadecapeptide insights exploring cytoprotective properties, gastrointestinal tissue support, and angiogenic pathway dynamics in pre-clinical studies.
Read Technical Paper
Advancing neuroscience through ACTH-derived neuroactive peptides: chemical validation, peptide purity metrics, and formulation stabilization techniques.
Read Technical Paper
Mitochondria-targeting tetrapeptide designed to selectively bind cardiolipin in the inner mitochondrial membrane, supporting cellular bioenergetics.
Read Technical PaperClear guidance on regulatory clearance, cold-chain logistics, batch testing, and ordering terms for pharmaceutical procurement teams.
Elevate your biopharmaceutical manufacturing with guaranteed cGMP quality, rigorous analytical documentation, and dedicated local commercial support in Mexico City.
Send Inquiry Now
